Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Epoetin zeta - Stada Arzneimittel/Pfizer

Drug Profile

Epoetin zeta - Stada Arzneimittel/Pfizer

Alternative Names: 1-165-Erythropoietin (human clone B03XA01), glycoform zeta; Darbepoetin alfa biosimilar - Bioceuticals; Darbepoetin alfa biosimilar - Hospira; Darbepoetin alfa biosimilar - Stada; Darbepoetin biosimilar - Bioceuticals; Darbepoetin biosimilar - Hospira; Darbepoetin biosimilar - Stada; Epo-zeta; Epoetin alfa biosimilar - Bioceuticals; Epoetin alfa biosimilar - Hospira; Epoetin alfa biosimilar - Stada; Epoetin alfa-epbx; Epoetin biosimilar - Bioceuticals; Epoetin biosimilar - Hospira; Epoetin biosimilar - Stada; Epoetin Hospira; Erythropoietin alfa - Bioceuticals; Erythropoietin alfa - Stada; Erythropoietin alfa biosimilar - Hospira; Retacrit; SB 309; Silapo

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BIOCEUTICALS Arzneimittel
  • Developer Pfizer; STADA Arzneimittel
  • Class Antianaemics; Recombinant erythropoietins
  • Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Anaemia

Most Recent Events

  • 02 Aug 2022 Vifor Pharma has been acquired by CSL and renamed to CSL Vifor
  • 14 Nov 2018 Launched for Anaemia in USA (SC, IV) (Pfizer website, December 2018)
  • 15 May 2018 Registered for Anaemia in Puerto Rico (IV)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top